Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2010
11/10/2010EP1874764B1 Imino-oxazolidines and use thereof as anticoagulants
11/10/2010EP1651677B1 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
11/10/2010EP1618113B1 Novel crystalline polymorphs of clopidogrel
11/10/2010EP1569692B1 Betaine and salicylic acid compositions
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN1561208B Methods to mobilize progenitor/stem cells
11/10/2010CN101883794A Novel chondroitin sulfate having decreased molecular weight and use thereof
11/10/2010CN101883793A Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the C1 domain of factor VIII
11/10/2010CN101880701A New method for preparing aprotinin derivatives by using methanol yeast
11/10/2010CN101880656A Agkistrodon halys venom thrombin and preparation method and application thereof
11/10/2010CN101880306A Stauntonia brachyanthera Hand-Mazz saponins components as well as preparation method and application thereof
11/10/2010CN101880286A Water-soluble amino-acid ester derivative of ginkgolide B
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101879306A Application of quasi adiponectin polypeptide segments used in drug for curing hypoxic-ischemic encephalopathy (HIE)
11/10/2010CN101879303A Blood-nourishing and uterus-nourishing Chinese medical pill
11/10/2010CN101879287A Method for preparing traditional Chinese medicine for treating excessive-heating uterine bleeding
11/10/2010CN101879270A Chinese medicinal injectable powder and quality control method thereof
11/10/2010CN101879255A Medicinal preparation used for treating frostbite and having thrombolysis effect
11/10/2010CN101879253A Pharmaceutical composition with functions of nourishing yin and supplementing blood
11/10/2010CN101879251A Composition for improving aplastic anemia symptoms as well as preparation method and application thereof
11/10/2010CN101879248A Medicine composition with blood tonification effect
11/10/2010CN101879232A Medicament for dissipating stasis, removing stroke and preventing and treating cardiovascular and cerebrovascular diseases
11/10/2010CN101879228A Medicine composition with spleen strengthening and blood tonification effects
11/10/2010CN101879206A Thrombolytic Chinese medicinal preparation
11/10/2010CN101879205A Traditional Chinese medicinal composition of angelica sinensis and safflower and application thereof
11/10/2010CN101879192A Medicine composition with blood tonification and beautification effects
11/10/2010CN101879181A Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
11/10/2010CN101879169A Compound preparation for treating relevant vascular diseases and preparation method thereof
11/10/2010CN101879165A Novel antihypertensive medicament compound preparation
11/10/2010CN101428015B Uses of icaritin in preparing medicament for preventing and treating endotoxemia
11/10/2010CN101427999B Frusemide oral solution and method of producing the same
11/10/2010CN101255169B Prasugrel salt and preparation method thereof
11/10/2010CN101249154B Blood-nourishing nerve-soothing oral liquid
11/10/2010CN101215307B Method for preparing hydroxyl carthamus tinctorius yellow color A
11/10/2010CN101161264B A Chinese medicine preparation for easing-off head and neck neoplasm radiotheraphy secondary reaction
11/10/2010CN101157710B Method for preparing iron supplementary carboxymethyl Chitosan oligosaccharide ferrous
11/10/2010CN101116694B Chinese traditional medicine for treating angitis, method for preparing the same and uses thereof
11/10/2010CN101081250B Potygonum multiflorum thunb extract medicament for treating anemia and the preparing method thereof
11/10/2010CN101036679B Gynura procumbens chewing gums
11/09/2010US7829771 cyanidin 3-glucoside pigment per 100 g of seeds which is much higher than an existing rice cultivar Heugjinju, antioxidant and thrombolytic activity
11/09/2010US7829580 Cyclic amine derivative having heteroaryl ring
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829095 Produced by hybridoma cell line DSM ACC 2533
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829078 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery; increasing the hematocrit and/or the reticulocyte count in a mammalian subject
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
11/09/2010CA2434937C Phenyl derivatives
11/04/2010WO2010127096A2 Novel therapeutic treatments using centhaquin
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126030A1 Spiroimidazolone derivative
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010WO2010124385A1 Processes for the preparation of rivaroxaban and intermediates thereof
11/04/2010WO2010124322A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010US20100280452 Medical devices having multiple layers
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280232 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100280177 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100280113 Compositions and methods for the treatment of cystic fibrosis
11/04/2010US20100280102 Double-stranded ribonucleic acid with increased effectiveness in an organism
11/04/2010US20100280100 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010US20100280064 Pharmaceutical composition having improved storage stability
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280045 Novel compounds
11/04/2010US20100280044 Enhanced erythropoiesis and iron metabolism
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100279960 Biotinylated hexadecasaccharides, preparation and use thereof
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279939 Recombinant human fibrinogen for treatment of bleeding in trauma and platelet disorders
11/04/2010US20100279938 Platelet Promoting Protein and The Usage Thereof
11/04/2010US20100279924 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279327 Method of treating diseases with parp inhibitors
11/04/2010US20100278997 Preparation for restenosis prevention
11/04/2010US20100278942 Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
11/04/2010US20100278941 Enhanced erythropoiesis and iron metabolism
11/04/2010US20100278933 Kinase inhibitor compounds
11/04/2010US20100278899 Edible film
11/04/2010US20100278879 Stable pharmaceutical composition and methods of using same
11/04/2010US20100278792 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
11/04/2010US20100278779 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
11/04/2010US20100278778 Method for bone marrow preservation or recovery
11/04/2010US20100278744 Preparation for restenosis prevention
11/04/2010CA2759828A1 Processes for the preparation of rivaroxaban and intermediates thereof
11/04/2010CA2759791A1 Novel therapeutic treatments using centhaquin
11/04/2010CA2759664A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/03/2010EP2245069A1 Humanized antibodies specific for von willebrand factor
11/03/2010EP2245031A2 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
11/03/2010EP2245030A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026
11/03/2010EP2244704A1 Treatment of aspirin resistance with betaine and/or betaine enriched molasses
11/03/2010EP2066683B1 Derivatives of 5-thioxylopyranose and use of same for treatment
11/03/2010EP1805155B1 Thrombopoietin activity modulating compounds and methods
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010CN1872054B Drop pills of coumarin acetic acid, and preparation method
11/03/2010CN101878224A Erythropoietin
11/03/2010CN101875961A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 671